| Year |
Citation |
Score |
| 2024 |
McCullar KS, Barker DH, McGeary JE, Saletin JM, Gredvig-Ardito C, Swift RM, Carskadon MA. Altered sleep architecture following consecutive nights of pre-sleep alcohol. Sleep. PMID 38205895 DOI: 10.1093/sleep/zsae003 |
0.563 |
|
| 2023 |
Haass-Koffler CL, Magill M, Cannella N, Brown JC, Aoun EG, Cioe PA, Sinha R, Swift RM, Ciccocioppo R, Leggio L. Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study. Addiction Biology. 28: e13288. PMID 37369125 DOI: 10.1111/adb.13288 |
0.543 |
|
| 2023 |
Jampel J, Quinn MJ, Catalano JL, Benca-Bachman CB, Brick L, Philip NS, Swift RM, McGeary JE. Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial. Bmj Open. 13: e066175. PMID 36717148 DOI: 10.1136/bmjopen-2022-066175 |
0.481 |
|
| 2023 |
Haass-Koffler CL, Magill M, Cannella N, Brown JC, Aoun EG, Cioe PA, Sinha R, Swift RM, Ciccocioppo R, Leggio L. Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial. Medrxiv : the Preprint Server For Health Sciences. PMID 36711869 DOI: 10.1101/2023.01.02.23284122 |
0.533 |
|
| 2021 |
Haass-Koffler CL, Perciballi R, Magill M, Loche A, Cacciaglia R, Leggio L, Swift RM. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder. Psychopharmacology. PMID 34731268 DOI: 10.1007/s00213-021-06008-1 |
0.454 |
|
| 2021 |
Goodyear K, Vasaturo-Kolodner TR, Kenna GA, Swift RM, Leggio L, Haass-Koffler CL. Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder. The American Journal of Drug and Alcohol Abuse. 47: 760-768. PMID 34582281 DOI: 10.1080/00952990.2021.1961799 |
0.405 |
|
| 2021 |
Brown ZE, Portis SM, Fleig CL, Vasaturo-Kolodner T, Swift RM, Haass-Koffler CL. Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic. Alcohol (Fayetteville, N.Y.). PMID 33434615 DOI: 10.1016/j.alcohol.2021.01.001 |
0.328 |
|
| 2020 |
Haass-Koffler CL, Piacentino D, Li X, Long VM, Lee MR, Swift RM, Kenna GA, Leggio L. Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study of Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 32997422 DOI: 10.1111/acer.14428 |
0.449 |
|
| 2020 |
Jiang JJ, Reupena SM, Naseri T, Swift RM, McGeary JE, McGarvey ST. Alcohol Consumption among Samoan Adults in 2010: Patterns, Correlates and Health Implications. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 32666120 DOI: 10.1093/Alcalc/Agaa066 |
0.653 |
|
| 2020 |
Haass-Koffler CL, Perciballi R, Brown ZE, Lee MR, Zywiak WH, Kurtis J, Swift RM, Leggio L. Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders. The American Journal On Addictions. PMID 32488890 DOI: 10.1111/Ajad.13064 |
0.403 |
|
| 2019 |
Haass-Koffler CL, Long VM, Farokhnia M, Magill M, Kenna GA, Swift RM, Leggio L. Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study. Neuropharmacology. 107711. PMID 31310775 DOI: 10.1016/j.neuropharm.2019.107711 |
0.481 |
|
| 2018 |
Haass-Koffler CL, Goodyear K, Zywiak WH, Leggio L, Kenna GA, Swift RM. Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29718153 DOI: 10.1093/alcalc/agy030 |
0.413 |
|
| 2018 |
Haass-Koffler CL, Swift RM, Leggio L. Noradrenergic targets for the treatment of alcohol use disorder. Psychopharmacology. PMID 29460163 DOI: 10.1007/s00213-018-4843-6 |
0.37 |
|
| 2018 |
Haass-Koffler CL, Goodyear K, Loche A, Long VM, Lobina C, Tran HH, Cacciaglia R, Swift RM, Colombo G, Leggio L. Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET7 3 with alcohol: A translational study in rats and humans. Journal of Psychopharmacology (Oxford, England). 269881117746904. PMID 29361897 DOI: 10.1177/0269881117746904 |
0.494 |
|
| 2017 |
Haass-Koffler CL, Goodyear K, Zywiak WH, Leggio L, Kenna GA, Swift RM. Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29281033 DOI: 10.1093/alcalc/agx108 |
0.394 |
|
| 2017 |
Haass-Koffler CL, Goodyear K, Zywiak WH, Magill M, Eltinge SE, Wallace PM, Long VM, Jayaram-Lindström N, Swift RM, Kenna GA, Leggio L. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug and Alcohol Dependence. 177: 23-28. PMID 28551590 DOI: 10.1016/j.drugalcdep.2017.03.016 |
0.482 |
|
| 2017 |
Barnett NP, Celio MA, Tidey JW, Murphy JG, Colby SM, Swift RM. A Preliminary Randomized Controlled Trial of Contingency Management for Alcohol Use Reduction Using a Transdermal Alcohol Sensor. Addiction (Abingdon, England). PMID 28107772 DOI: 10.1111/Add.13767 |
0.483 |
|
| 2017 |
Haass-Koffler CL, Akhlaghi F, Swift RM, Leggio L. Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks? Journal of Psychopharmacology (Oxford, England). 269881116684338. PMID 28093021 DOI: 10.1177/0269881116684338 |
0.392 |
|
| 2017 |
Goodyear K, Haass-Koffler C, Zywiak W, Magill M, Wallace P, Swift R, Kenna G, Leggio L. Family history density of alcoholism and blood pressure as moderators for drinking reduction in alcohol-dependent individuals treated with doxazosin Alcohol. 60: 231. DOI: 10.1016/j.alcohol.2017.02.302 |
0.457 |
|
| 2017 |
Swift R, Wood J, Franco J, Cacciaglia R. Effect of the mGluR5 modulator GET 73 on alcohol pharmaco-kinetics and pharmacodynamics and alcohol craving in a human laboratory model Alcohol. 60: 225. DOI: 10.1016/j.alcohol.2017.02.276 |
0.574 |
|
| 2017 |
Haass-Koffler CL, Henry AT, Melkus G, Simms JA, Naemmuddin M, Nielsen CK, Lasek AW, Magill M, Schwandt ML, Momenan R, Hodgkinson CA, Bartlett SE, Swift RM, Bonci A, Leggio L. A chimeric approach to evaluate the role of corticotropin releasing factor in alcohol use disorder Alcohol. 60: 222-223. DOI: 10.1016/J.Alcohol.2017.02.267 |
0.342 |
|
| 2016 |
Subbaraman MS, Metrik J, Patterson D, Swift R. Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes. Addiction (Abingdon, England). PMID 27865015 DOI: 10.1111/add.13693 |
0.544 |
|
| 2016 |
Haass-Koffler CL, Henry AT, Melkus G, Simms JA, Naemmuddin M, Nielsen CK, Lasek AW, Magill M, Schwandt ML, Momenan R, Hodgkinson CA, Bartlett SE, Swift RM, Bonci A, Leggio L. Defining the role of corticotropin releasing factor binding protein in alcohol consumption. Translational Psychiatry. 6: e953. PMID 27845775 DOI: 10.1038/Tp.2016.208 |
0.465 |
|
| 2016 |
Mann K, Torup L, Sørensen P, Gual A, Swift R, Walker B, van den Brink W. Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27842940 DOI: 10.1016/j.euroneuro.2016.10.008 |
0.563 |
|
| 2016 |
Leventhal AM, Kirkpatrick MG, Pester MS, McGeary JE, Swift RM, Sussman S, Kahler CW. Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology. PMID 27771748 DOI: 10.1007/S00213-016-4462-Z |
0.474 |
|
| 2016 |
Haass-Koffler CL, Giovenco DE, Lee MR, Zywiak WH, de la Monte SM, Kenna GA, Swift RM, Leggio L. Serum Insulin Levels are Reduced by Intravenous Ghrelin Administration but do not Correlate with Alcohol Craving in Alcohol Dependent Individuals. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207912 DOI: 10.1093/ijnp/pyw048 |
0.413 |
|
| 2016 |
Miranda R, Treloar H, Blanchard A, Justus A, Monti PM, Chun T, Swift R, Tidey JW, Gwaltney CJ. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study. Addiction Biology. PMID 26752416 DOI: 10.1111/Adb.12350 |
0.347 |
|
| 2015 |
Kirkpatrick MG, Goldenson NI, Kapadia N, Kahler CW, de Wit H, Swift RM, McGeary JE, Sussman S, Leventhal AM. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology. PMID 26429791 DOI: 10.1007/S00213-015-4091-Y |
0.566 |
|
| 2015 |
Haass-Koffler CL, Aoun EG, Swift RM, de la Monte SM, Kenna GA, Leggio L. Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving. Translational Psychiatry. 5: e646. PMID 26418274 DOI: 10.1038/tp.2015.140 |
0.481 |
|
| 2015 |
Creech SK, Swift R, Zlotnick C, Taft C, Street AE. Combat Exposure, Mental Health, and Relationship Functioning Among Women Veterans of the Afghanistan and Iraq Wars. Journal of Family Psychology : Jfp : Journal of the Division of Family Psychology of the American Psychological Association (Division 43). PMID 26348108 DOI: 10.1037/Fam0000145 |
0.311 |
|
| 2015 |
Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB, Swift RM, Leggio L. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial. Addiction Biology. PMID 26037245 DOI: 10.1111/adb.12275 |
0.445 |
|
| 2015 |
Farokhnia M, Edwards SM, Bollinger J, Amodio J, Zywiak WH, Tidey JW, Swift RM, Kenna GA, Leggio L. T76. Baclofen as a pharmacotherapy for the treatment of concurrent alcohol and nicotine dependence: a double-blind, placebo-controlled, randomized trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1560. PMID 25868070 DOI: 10.1038/Npp.2015.29 |
0.377 |
|
| 2015 |
MacKillop J, Few LR, Stojek MK, Murphy CM, Malutinok SF, Johnson FT, Hofmann SG, McGeary JE, Swift RM, Monti PM. D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach. Translational Psychiatry. 5: e544. PMID 25849983 DOI: 10.1038/Tp.2015.41 |
0.688 |
|
| 2015 |
Haass-Koffler CL, Leggio L, Davidson D, Swift RM. Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study. Alcoholism, Clinical and Experimental Research. 39: 594-602. PMID 25833022 DOI: 10.1111/Acer.12658 |
0.511 |
|
| 2015 |
Leggio L, Zywiak WH, Edwards SM, Tidey JW, Swift RM, Kenna GA. Erratum to: a preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers. Psychopharmacology. 232: 1667. PMID 25804430 DOI: 10.1007/s00213-015-3916-z |
0.488 |
|
| 2015 |
Swift RM, Aston ER. Pharmacotherapy for alcohol use disorder: current and emerging therapies. Harvard Review of Psychiatry. 23: 122-33. PMID 25747925 DOI: 10.1097/Hrp.0000000000000079 |
0.441 |
|
| 2015 |
Aoun EG, Lee MR, Haass-Koffler CL, Swift RM, Addolorato G, Kenna GA, Leggio L. Relationship between the thyroid axis and alcohol craving. Alcohol and Alcoholism (Oxford, Oxfordshire). 50: 24-9. PMID 25433251 DOI: 10.1093/alcalc/agu085 |
0.357 |
|
| 2015 |
Leggio L, Zywiak WH, Edwards SM, Tidey JW, Swift RM, Kenna GA. A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers. Psychopharmacology. 232: 233-43. PMID 24973894 DOI: 10.1007/S00213-014-3652-9 |
0.517 |
|
| 2015 |
Kenna G, Haass-Koffler C, Swift R, Zywiak W, Brickley M, Edwards S, Leggio L. P86A PILOT DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL USING DOXAZOSIN FOR ALCOHOL DEPENDENCE Alcohol and Alcoholism. 50: i67.2-i67. DOI: 10.1093/alcalc/agv080.86 |
0.534 |
|
| 2015 |
Kirkpatrick M, Goldenson N, Kahler C, de Wit H, Swift R, McGeary J, Leventhal A. Emotional traits predict individual differences in amphetamine-induced positive mood Drug and Alcohol Dependence. 156: e113. DOI: 10.1016/J.Drugalcdep.2015.07.313 |
0.514 |
|
| 2014 |
Miranda R, MacKillop J, Treloar H, Blanchard A, Tidey JW, Swift RM, Chun T, Rohsenow DJ, Monti PM. Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments. Addiction Biology. PMID 25353306 DOI: 10.1111/Adb.12192 |
0.538 |
|
| 2014 |
Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings. Alcohol (Fayetteville, N.Y.). 48: 515-22. PMID 25212749 DOI: 10.1016/J.Alcohol.2014.04.005 |
0.646 |
|
| 2014 |
Vuittonet CL, Halse M, Leggio L, Fricchione SB, Brickley M, Haass-Koffler CL, Tavares T, Swift RM, Kenna GA. Pharmacotherapy for alcoholic patients with alcoholic liver disease. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 71: 1265-76. PMID 25027533 DOI: 10.2146/ajhp140028 |
0.407 |
|
| 2014 |
Quinn AE, Rosen RK, McGeary JE, Amoa F, Kranzler HR, Francazio S, McGarvey ST, Swift RM. Translating the semi-structured assessment for drug dependence and alcoholism in the Western Pacific: rationale, study design and reliability of alcohol dependence. Alcohol and Alcoholism (Oxford, Oxfordshire). 49: 525-30. PMID 24936588 DOI: 10.1093/Alcalc/Agu035 |
0.67 |
|
| 2014 |
Leggio L, Zywiak WH, Fricchione SR, Edwards SM, de la Monte SM, Swift RM, Kenna GA. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. Biological Psychiatry. 76: 734-41. PMID 24775991 DOI: 10.1016/j.biopsych.2014.03.019 |
0.521 |
|
| 2014 |
Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Vuittonet C, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study. Alcoholism, Clinical and Experimental Research. 38: 1567-74. PMID 24773166 DOI: 10.1111/Acer.12410 |
0.662 |
|
| 2014 |
Rohsenow DJ, Martin RA, Monti PM, Colby SM, Day AM, Abrams DB, Sirota AD, Swift RM. Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment. Journal of Substance Abuse Treatment. 46: 346-55. PMID 24210533 DOI: 10.1016/J.Jsat.2013.10.002 |
0.355 |
|
| 2014 |
Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Justus A, Swift RM, Tidey J, Gwaltney CJ, Ramirez J. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addiction Biology. 19: 941-54. PMID 23489253 DOI: 10.1111/Adb.12050 |
0.513 |
|
| 2014 |
Swift RM, Aoun EG. Pharmacotherapy of Alcohol and Drug Dependence Current Behavioral Neuroscience Reports. 2: 30-39. DOI: 10.1007/s40473-014-0029-7 |
0.434 |
|
| 2013 |
Bidwell LC, MacKillop J, Murphy JG, Grenga A, Swift RM, McGeary JE. Biphasic effects of alcohol on delay and probability discounting. Experimental and Clinical Psychopharmacology. 21: 214-21. PMID 23750692 DOI: 10.1037/A0032284 |
0.687 |
|
| 2013 |
Leggio L, Zywiak WH, McGeary JE, Edwards S, Fricchione SR, Shoaff JR, Addolorato G, Swift RM, Kenna GA. A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacology, Biochemistry, and Behavior. 103: 784-91. PMID 23262301 DOI: 10.1016/J.Pbb.2012.11.013 |
0.723 |
|
| 2013 |
Johnson B, Seneviratne C, Franklin J, Beckett K, Ma J, Ait-Daoud N, Payne T, Johnson B, Li M, Ait-Daoud N, Kenna G, Zywiak WH, McGeary JE, Swift RM, Clifford JS, et al. S02 * SEROTONIN SYSTEM IN ALCOHOLISM: INDIVIDUAL DIFFERENCES AND TREATMENT Alcohol and Alcoholism. 48: i3-i4. DOI: 10.1093/Alcalc/Agt074 |
0.672 |
|
| 2012 |
Kenna GA, Swift RM, Hillemacher T, Leggio L. The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans. Neuropsychology Review. 22: 211-28. PMID 22772772 DOI: 10.1007/s11065-012-9209-y |
0.498 |
|
| 2012 |
Leggio L, Ferrulli A, Zambon A, Caputo F, Kenna GA, Swift RM, Addolorato G. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addictive Behaviors. 37: 561-4. PMID 22244707 DOI: 10.1016/j.addbeh.2011.12.010 |
0.486 |
|
| 2012 |
Litten RZ, Fertig JB, Falk DE, Ryan ML, Mattson ME, Collins JF, Murtaugh C, Ciraulo D, Green AI, Johnson B, Pettinati H, Swift R, Afshar M, Brunette MF, Tiouririne NA, et al. A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcoholism, Clinical and Experimental Research. 36: 406-16. PMID 21950727 DOI: 10.1111/J.1530-0277.2011.01649.X |
0.556 |
|
| 2012 |
Leggio L, Ferrulli A, Cardone S, Nesci A, Miceli A, Malandrino N, Capristo E, Canestrelli B, Monteleone P, Kenna GA, Swift RM, Addolorato G. Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addiction Biology. 17: 452-64. PMID 21392177 DOI: 10.1111/j.1369-1600.2010.00308.x |
0.51 |
|
| 2011 |
Leggio L, Kenna GA, Ferrulli A, Zywiak WH, Caputo F, Swift RM, Addolorato G. Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease. Human Psychopharmacology. 26: 554-9. PMID 22095793 DOI: 10.1002/hup.1244 |
0.51 |
|
| 2011 |
Swift R, Oslin DW, Alexander M, Forman R. Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. Journal of Studies On Alcohol and Drugs. 72: 1012-8. PMID 22051215 DOI: 10.15288/Jsad.2011.72.1012 |
0.433 |
|
| 2011 |
Barnett NP, Tidey J, Murphy JG, Swift R, Colby SM. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug and Alcohol Dependence. 118: 391-9. PMID 21665385 DOI: 10.1016/J.Drugalcdep.2011.04.023 |
0.586 |
|
| 2011 |
Capone C, Kahler CW, Swift RM, O'Malley SS. Does family history of alcoholism moderate naltrexone's effects on alcohol use? Journal of Studies On Alcohol and Drugs. 72: 135-40. PMID 21138720 |
0.486 |
|
| 2011 |
Leggio L, Addolorato G, Cippitelli A, Jerlhag E, Kampov-Polevoy AB, Swift RM. Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin. Alcoholism, Clinical and Experimental Research. 35: 194-202. PMID 21058960 DOI: 10.1111/j.1530-0277.2010.01334.x |
0.443 |
|
| 2010 |
Swift R. Medications acting on the dopaminergic system in the treatment of alcoholic patients. Current Pharmaceutical Design. 16: 2136-40. PMID 20482513 DOI: 10.2174/138161210791516323 |
0.49 |
|
| 2010 |
Leggio L, Cardone S, Ferrulli A, Kenna GA, Diana M, Swift RM, Addolorato G. Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence. Current Pharmaceutical Design. 16: 2159-18. PMID 20482506 DOI: 10.2174/138161210791516369 |
0.425 |
|
| 2010 |
Ray LA, Miranda R, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. Journal of Abnormal Psychology. 119: 115-25. PMID 20141248 DOI: 10.1037/A0017550 |
0.696 |
|
| 2010 |
MacKillop J, Miranda R, Monti PM, Ray LA, Murphy JG, Rohsenow DJ, McGeary JE, Swift RM, Tidey JW, Gwaltney CJ. Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. Journal of Abnormal Psychology. 119: 106-14. PMID 20141247 DOI: 10.1037/A0017513 |
0.695 |
|
| 2009 |
Kenna GA, Lomastro TL, Schiesl A, Leggio L, Swift RM. Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Current Drug Abuse Reviews. 2: 135-42. PMID 19630744 DOI: 10.2174/1874473710902020135 |
0.478 |
|
| 2009 |
Kenna GA, Leggio L, Swift RM. A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol. Human Psychopharmacology. 24: 465-72. PMID 19551762 DOI: 10.1002/hup.1042 |
0.522 |
|
| 2009 |
Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcoholism, Clinical and Experimental Research. 33: 1539-44. PMID 19485973 DOI: 10.1111/J.1530-0277.2009.00982.X |
0.361 |
|
| 2009 |
Ray LA, Miranda R, MacKillop J, McGeary J, Tidey JW, Rohsenow DJ, Gwaltney C, Swift RW, Monti PM. A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Experimental and Clinical Psychopharmacology. 17: 122-9. PMID 19331489 DOI: 10.1037/A0015700 |
0.619 |
|
| 2009 |
Leggio L, Kenna GA, Fenton M, Bonenfant E, Swift RM. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychology Review. 19: 115-29. PMID 19184441 DOI: 10.1007/S11065-008-9080-Z |
0.403 |
|
| 2009 |
Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D, Yuan Q, Goldman D. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcoholism, Clinical and Experimental Research. 33: 383-93. PMID 19053977 DOI: 10.1111/J.1530-0277.2008.00846.X |
0.343 |
|
| 2009 |
Kenna GA, Zywiak WH, McGeary JE, Leggio L, McGeary C, Wang S, Grenga A, Swift RM. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline. Alcoholism, Clinical and Experimental Research. 33: 315-23. PMID 19032576 DOI: 10.1111/J.1530-0277.2008.00835.X |
0.653 |
|
| 2009 |
Swift R, Leggio L. Adjunctive pharmacotherapy in the treatment of alcohol and drug dependence Evidence-Based Addiction Treatment. 287-310. DOI: 10.1016/B978-0-12-374348-0.00015-X |
0.43 |
|
| 2008 |
Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. Journal of Studies On Alcohol and Drugs. 69: 878-84. PMID 18925346 DOI: 10.15288/Jsad.2008.69.878 |
0.464 |
|
| 2008 |
Leggio L, Ferrulli A, Cardone S, Malandrino N, Mirijello A, D'Angelo C, Vonghia L, Miceli A, Capristo E, Kenna GA, Gasbarrini G, Swift RM, Addolorato G. Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study. Alcoholism, Clinical and Experimental Research. 32: 2047-53. PMID 18828809 DOI: 10.1111/j.1530-0277.2008.00792.x |
0.377 |
|
| 2008 |
Friedmann PD, Rose JS, Swift R, Stout RL, Millman RP, Stein MD. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial. Alcoholism, Clinical and Experimental Research. 32: 1652-60. PMID 18616688 DOI: 10.1111/j.1530-0277.2008.00742.x |
0.404 |
|
| 2008 |
Ray LA, Hutchison KE, MacKillop J, Miranda R, Audette A, Swift R, Monti PM. Effects of naltrexone during the descending limb of the blood alcohol curve. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 257-64. PMID 18612879 DOI: 10.1080/10550490802138400 |
0.733 |
|
| 2008 |
Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM, et al. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Archives of Internal Medicine. 168: 1188-99. PMID 18541827 DOI: 10.1001/Archinte.168.11.1188 |
0.381 |
|
| 2008 |
Rohsenow DJ, Tidey JW, Miranda R, McGeary JE, Swift RM, Hutchison KE, Sirota AD, Monti PM. Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Experimental and Clinical Psychopharmacology. 16: 215-22. PMID 18540781 DOI: 10.1037/1064-1297.16.3.215 |
0.628 |
|
| 2008 |
Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, Swift RM, Addolorato G. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study. Alcohol (Fayetteville, N.Y.). 42: 375-81. PMID 18486430 DOI: 10.1016/j.alcohol.2008.03.128 |
0.413 |
|
| 2008 |
Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry. 65: 135-44. PMID 18250251 DOI: 10.1001/Archpsyc.65.2.135 |
0.575 |
|
| 2008 |
Miranda R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcoholism, Clinical and Experimental Research. 32: 489-97. PMID 18215213 DOI: 10.1111/J.1530-0277.2007.00592.X |
0.744 |
|
| 2008 |
Leggio L, Kenna GA, Swift RM. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1106-17. PMID 18029075 DOI: 10.1016/j.pnpbp.2007.09.021 |
0.468 |
|
| 2008 |
Tidey JW, Monti PM, Rohsenow DJ, Gwaltney CJ, Miranda R, McGeary JE, MacKillop J, Swift RM, Abrams DB, Shiffman S, Paty JA. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcoholism, Clinical and Experimental Research. 32: 58-66. PMID 18028530 DOI: 10.1111/J.1530-0277.2007.00545.X |
0.724 |
|
| 2008 |
Johnson BA, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM. Topiramate as treatment for alcohol dependence: Reply [4] Jama - Journal of the American Medical Association. 299: 406-407. DOI: 10.1001/Jama.299.4.406 |
0.495 |
|
| 2007 |
Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. Jama. 298: 1641-51. PMID 17925516 DOI: 10.1001/Jama.298.14.1641 |
0.493 |
|
| 2007 |
Ray LA, Miranda R, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology. 193: 449-56. PMID 17484067 DOI: 10.1007/S00213-007-0794-Z |
0.715 |
|
| 2007 |
Swift R. Emerging approaches to managing alcohol dependence. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 64: S12-22. PMID 17322178 DOI: 10.2146/ajhp060644 |
0.56 |
|
| 2007 |
Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Experimental and Clinical Psychopharmacology. 15: 81-92. PMID 17295587 DOI: 10.1037/1064-1297.15.1.81 |
0.506 |
|
| 2007 |
Davidson D, Gulliver SB, Longabaugh R, Wirtz PW, Swift R. Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone? Journal of Studies On Alcohol and Drugs. 68: 238-47. PMID 17286342 DOI: 10.15288/Jsad.2007.68.238 |
0.47 |
|
| 2006 |
McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R, Miranda R. Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcoholism, Clinical and Experimental Research. 30: 1288-96. PMID 16899031 DOI: 10.1111/J.1530-0277.2006.00156.X |
0.722 |
|
| 2006 |
Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, ... ... Swift R, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Jama. 295: 2003-17. PMID 16670409 DOI: 10.1001/Jama.295.17.2003 |
0.459 |
|
| 2006 |
Kranzler HR, Koob G, Gastfriend DR, Swift RM, Willenbring ML. Advances in the pharmacotherapy of alcoholism: challenging misconceptions. Alcoholism, Clinical and Experimental Research. 30: 272-81. PMID 16441276 DOI: 10.1111/j.1530-0277.2006.00022.x |
0.451 |
|
| 2006 |
Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1310-7. PMID 16237394 DOI: 10.1038/Sj.Npp.1300917 |
0.729 |
|
| 2006 |
Bohn MJ, Swift RM. Prevalence and impact of alcohol dependence Journal of Clinical Psychiatry. 67: 6-13. |
0.478 |
|
| 2006 |
Swift RM. Introduction: Practical pharmacotherapeutic management strategies for patients with alcohol dependence Journal of Clinical Psychiatry. 67: 3-5. |
0.374 |
|
| 2005 |
Swift R, Pettinati HM. Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence. Journal of Studies On Alcohol. Supplement. 141-7; discussion 14. PMID 16223065 DOI: 10.15288/Jsas.2005.S15.141 |
0.462 |
|
| 2005 |
Weiss RD, Locastro JS, Swift R, Zweben A, Miller WR, Longabaugh R, Hosking JD. Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy-psychotherapy research study of alcohol dependence. Journal of Studies On Alcohol. Supplement. 43-9; discussion 33. PMID 16223055 DOI: 10.15288/Jsas.2005.S15.43 |
0.562 |
|
| 2005 |
Johnson BA, Mann K, Willenbring ML, Litten RZ, Swift RM, Lesch OM, Berglund M. Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry. Alcoholism, Clinical and Experimental Research. 29: 1528-40. PMID 16156050 DOI: 10.1097/01.Alc.0000174690.63787.Fc |
0.337 |
|
| 2005 |
Johnson BA, Swift RM, Addolorato G, Ciraulo DA, Myrick H. Safety and efficacy of GABAergic medications for treating alcoholism. Alcoholism, Clinical and Experimental Research. 29: 248-54. PMID 15714047 DOI: 10.1097/01.Alc.0000153542.10188.B0 |
0.462 |
|
| 2005 |
Gulliver SB, Longabaugh R, Davidson D, Swift R. The development of a broad spectrum treatment for patients with alcohol dependence in early recovery Cognitive and Behavioral Practice. 12: 53-63. DOI: 10.1016/S1077-7229(05)80039-2 |
0.502 |
|
| 2005 |
Swift R, Pettinati HM. Choosing pharmacotherapies for the COMBINE study - Process and procedures: An investigational approach to combination pharmacotherapy for the treatment of alcohol dependence Journal of Studies On Alcohol. 66: 141-147. |
0.419 |
|
| 2004 |
Kenna GA, McGeary JE, Swift RM. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 61: 2380-8. PMID 15581261 DOI: 10.1093/Ajhp/61.22.2380 |
0.701 |
|
| 2004 |
Kenna GA, McGeary JE, Swift RM. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 61: 2272-9. PMID 15552634 DOI: 10.1093/Ajhp/61.21.2272 |
0.701 |
|
| 2004 |
Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 24: 421-8. PMID 15232334 DOI: 10.1097/01.Jcp.0000130555.63254.73 |
0.542 |
|
| 2004 |
Johnson BA, Swift RM, Ait-Daoud N, DiClemente CC, Javors MA, Malcolm RJ. Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics. Alcoholism, Clinical and Experimental Research. 28: 295-301. PMID 15112937 DOI: 10.1097/01.Alc.0000113409.47937.6C |
0.501 |
|
| 2004 |
Hutchison KE, Rutter MC, Niaura R, Swift RM, Pickworth WB, Sobik L. Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology. 175: 407-13. PMID 15042276 DOI: 10.1007/S00213-004-1837-3 |
0.52 |
|
| 2004 |
Pierucci-Lagha A, Feinn R, Modesto-Lowe V, Swift R, Nellissery M, Covault J, Kranzler HR. Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence. Psychopharmacology. 171: 340-8. PMID 13680073 DOI: 10.1007/S00213-003-1588-6 |
0.547 |
|
| 2004 |
Monti PM, Rohsenow D, Tidey J, McGeary J, Swift R. NALTREXONE, CRAVING FOR ALCOHOL AND DRINKING: LABORATORY AND ECOLOGICAL ASSESSMENTS. Alcoholism: Clinical & Experimental Research. 28: 65A. DOI: 10.1097/00000374-200408002-00351 |
0.72 |
|
| 2004 |
Swift RM, Tempelman L, Brown GR. A WEARABLE TRANSDERMAL ALCOHOL SENSOR FOR MEASUREMENT OF ALCOHOL DRINKING. Alcoholism: Clinical & Experimental Research. 28: 41A. DOI: 10.1097/00000374-200408002-00207 |
0.464 |
|
| 2004 |
McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R. THE DRD4 GENE AND CUE-INDUCED ALCOHOL CRAVING IN A NALTREXONE TRIAL: PRELIMINARY RESULTS. Alcoholism: Clinical & Experimental Research. 28: 30A. DOI: 10.1097/00000374-200408002-00140 |
0.697 |
|
| 2003 |
Anton RF, Swift RM. Current pharmacotherapies of alcoholism: a U.S. perspective. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 12: S53-68. PMID 14972780 |
0.508 |
|
| 2003 |
Hutchison KE, Wooden A, Swift RM, Smolen A, McGeary J, Adler L, Paris L. Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1882-8. PMID 12888781 DOI: 10.1038/Sj.Npp.1300264 |
0.778 |
|
| 2003 |
Swift RM. Topiramate for the treatment of alcohol dependence: initiating abstinence. Lancet. 361: 1666-7. PMID 12767727 DOI: 10.1016/S0140-6736(03)13378-8 |
0.495 |
|
| 2003 |
Zywiak WH, Stout RL, Trefry WB, LaGrutta JE, Lawson CC, Khan N, Swift RM, Schneider RJ. Alcohol relapses associated with September 11, 2001: a case report. Substance Abuse. 24: 123-8. PMID 12766379 DOI: 10.1080/08897070309511540 |
0.357 |
|
| 2003 |
Rohsenow DJ, Monti PM, Colby SM, Gulliver SB, Swift RM, Abrams DB. Naltrexone treatment for alcoholics: effect on cigarette smoking rates. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 5: 231-6. PMID 12745496 DOI: 10.1080/1462220031000073298 |
0.341 |
|
| 2003 |
Thomas CP, Wallack SS, Lee S, McCarty D, Swift R. Research to practice: adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment. 24: 1-11. PMID 12646325 DOI: 10.1016/S0740-5472(02)00319-7 |
0.525 |
|
| 2002 |
Hitsman B, Abrams DB, Shadel WG, Niaura R, Borrelli B, Emmons KM, Brown RA, Swift RM, Monti PM, Rohsenow DJ, Colby SM. Depressive symptoms and readiness to quit smoking among cigarette smokers in outpatient alcohol treatment. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 16: 264-8. PMID 12236463 DOI: 10.1037/0893-164X.16.3.264 |
0.355 |
|
| 2002 |
Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM. The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 21: 139-46. PMID 11950104 DOI: 10.1037//0278-6133.21.2.139 |
0.761 |
|
| 2002 |
Smoger SH, Looney SW, Blondell RD, Wieland LS, Sexton L, Rhodes SB, Swift RM. Hospital Use of Ethanol Survey (HUES): preliminary results. Journal of Addictive Diseases. 21: 65-73. PMID 11916373 DOI: 10.1300/J069V21N02_06 |
0.474 |
|
| 2002 |
Davidson D, Hutchison K, Dagon C, Swift R. Assessing the stimulant effects of alcohol in humans. Pharmacology, Biochemistry, and Behavior. 72: 151-6. PMID 11900782 DOI: 10.1016/S0091-3057(01)00758-4 |
0.718 |
|
| 2001 |
Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcoholism, Clinical and Experimental Research. 25: 1634-47. PMID 11707638 DOI: 10.1111/J.1530-0277.2001.Tb02170.X |
0.394 |
|
| 2001 |
Hutchison KE, Swift R, Rohsenow DJ, Monti PM, Davidson D, Almeida A. Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacology. 155: 27-34. PMID 11374333 DOI: 10.1007/S002130000629 |
0.739 |
|
| 2001 |
Flannery BA, Roberts AJ, Cooney N, Swift RM, Anton RF, Rohsenow DJ. The role of craving in alcohol use, dependence, and treatment. Alcoholism, Clinical and Experimental Research. 25: 299-308. PMID 11236847 |
0.511 |
|
| 2000 |
Swift RM. Opioid antagonists and alcoholism treatment. Cns Spectrums. 5: 49-57. PMID 18296998 |
0.407 |
|
| 2000 |
Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. Journal of Abnormal Psychology. 109: 738-42. PMID 11195999 DOI: 10.1037/0021-843X.109.4.738 |
0.707 |
|
| 2000 |
Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, Gordon A, Eaton CA. Predictors of compliance with naltrexone among alcoholics. Alcoholism, Clinical and Experimental Research. 24: 1542-9. PMID 11045863 DOI: 10.1111/J.1530-0277.2000.Tb04573.X |
0.45 |
|
| 2000 |
Hutchison KE, Niaura R, Swift R. The effects of smoking high nicotine cigarettes on prepulse inhibition, startle latency, and subjective responses. Psychopharmacology. 150: 244-52. PMID 10923751 DOI: 10.1007/S002130000399 |
0.476 |
|
| 2000 |
Swift R. Transdermal alcohol measurement for estimation of blood alcohol concentration. Alcoholism, Clinical and Experimental Research. 24: 422-3. PMID 10798575 DOI: 10.1111/J.1530-0277.2000.Tb02006.X |
0.543 |
|
| 2000 |
Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, Gordon A, Eaton CA. Predictors of Compliance with Naltrexone Among Alcoholics Alcoholism: Clinical and Experimental Research. 24: 1542-1549. DOI: 10.1111/j.1530-0277.2000.tb04573.x |
0.515 |
|
| 1999 |
Swift RM. Medications and alcohol craving. Alcohol Research & Health : the Journal of the National Institute On Alcohol Abuse and Alcoholism. 23: 207-13. PMID 10890816 |
0.447 |
|
| 1999 |
Hutchison KE, Wood MD, Swift R. Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans. Experimental and Clinical Psychopharmacology. 7: 493-501. PMID 10609984 DOI: 10.1037/1064-1297.7.4.493 |
0.528 |
|
| 1999 |
Palfai T, Davidson D, Swift R. Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies. Experimental and Clinical Psychopharmacology. 7: 266-73. PMID 10472515 DOI: 10.1037/1064-1297.7.3.266 |
0.566 |
|
| 1999 |
Hutchison KE, Niaura R, Swift R. Smoking cues decrease prepulse inhibition of the startle response and increase subjective craving in humans. Experimental and Clinical Psychopharmacology. 7: 250-6. PMID 10472513 DOI: 10.1037//1064-1297.7.3.250 |
0.536 |
|
| 1999 |
Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB. Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcoholism, Clinical and Experimental Research. 23: 1386-94. PMID 10470982 DOI: 10.1111/J.1530-0277.1999.Tb04361.X |
0.686 |
|
| 1999 |
Hutchison KE, Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology. 143: 394-400. PMID 10367557 DOI: 10.1007/S002130050964 |
0.549 |
|
| 1999 |
Swift RM. Drug therapy for alcohol dependence. The New England Journal of Medicine. 340: 1482-90. PMID 10320388 DOI: 10.1056/NEJM199905133401907 |
0.393 |
|
| 1999 |
Hutchison KE, Monti PM, Rohsenow DJ, Swift RM, Colby SM, Gnys M, Niaura RS, Sirota AD. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results. Psychopharmacology. 142: 139-43. PMID 10102765 DOI: 10.1007/S002130050872 |
0.487 |
|
| 1999 |
Davidson D, Palfai T, Bird C, Swift R. Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcoholism, Clinical and Experimental Research. 23: 195-203. PMID 10069545 DOI: 10.1111/J.1530-0277.1999.Tb04099.X |
0.584 |
|
| 1998 |
Swift R, Davidson D. Alcohol hangover: mechanisms and mediators. Alcohol Health and Research World. 22: 54-60. PMID 15706734 |
0.484 |
|
| 1998 |
Swift RM, Duncan D, Nirenberg T, Femino J. Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism. Journal of Addictive Diseases. 17: 35-47. PMID 9789158 DOI: 10.1300/J069v17n03_04 |
0.492 |
|
| 1998 |
Swift R, Davidson D, Rosen S, Fitz E, Camara P. Naltrexone effects on diazepam intoxication and pharmacokinetics in humans. Psychopharmacology. 135: 256-62. PMID 9498728 DOI: 10.1007/S002130050507 |
0.578 |
|
| 1998 |
Swift RM. Pharmacologic Treatments for Drug and Alcohol Dependence: Experimental and Standard Therapies Psychiatric Annals. 28: 697-702. DOI: 10.3928/0048-5713-19981201-08 |
0.382 |
|
| 1997 |
Hutchison KE, Rohsenow D, Monti P, Palfai T, Swift R. Prepulse inhibition of the startle reflex: preliminary study of the effects of a low dose of alcohol in humans. Alcoholism, Clinical and Experimental Research. 21: 1312-9. PMID 9347095 DOI: 10.1111/J.1530-0277.1997.Tb04454.X |
0.73 |
|
| 1997 |
Davidson D, Camara P, Swift R. Behavioral effects and pharmacokinetics of low-dose intravenous alcohol in humans. Alcoholism, Clinical and Experimental Research. 21: 1294-9. PMID 9347092 DOI: 10.1111/J.1530-0277.1997.Tb04451.X |
0.59 |
|
| 1997 |
Swift RM. The pharmacological treatment of alcohol dependence. Medicine and Health, Rhode Island. 80: 91-3. PMID 9117944 |
0.496 |
|
| 1997 |
Swift R. Biological aspects of alcoholism: Implications for prevention, treatment and policy B. Tabakoff and P. Hoffmann, Editors Seattle, WA: Hogrefe & Huber Publishers, $39.00, 308 pages Journal of Substance Abuse Treatment. 14: 200-201. DOI: 10.1016/S0740-5472(97)00084-6 |
0.361 |
|
| 1996 |
Swift RM, Davidson D, Whelihan W, Kuznetsov O. Ondansetron alters human alcohol intoxication. Biological Psychiatry. 40: 514-21. PMID 8879472 DOI: 10.1016/0006-3223(95)00432-7 |
0.522 |
|
| 1996 |
Davidson D, Swift R, Fitz E. Naltrexone increases the latency to drink alcohol in social drinkers. Alcoholism, Clinical and Experimental Research. 20: 732-9. PMID 8800392 DOI: 10.1111/J.1530-0277.1996.Tb01679.X |
0.609 |
|
| 1995 |
Swift RM. Effect of naltrexone on human alcohol consumption. The Journal of Clinical Psychiatry. 56: 24-9. PMID 7673102 |
0.492 |
|
| 1994 |
Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H. Naltrexone-induced alterations in human ethanol intoxication. The American Journal of Psychiatry. 151: 1463-7. PMID 8092339 |
0.323 |
|
| 1993 |
Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM. Development and validation of the Biphasic Alcohol Effects Scale. Alcoholism, Clinical and Experimental Research. 17: 140-6. PMID 8452195 DOI: 10.1111/J.1530-0277.1993.Tb00739.X |
0.476 |
|
| 1993 |
Swift RM. Transdermal measurement of alcohol consumption. Addiction (Abingdon, England). 88: 1037-9. PMID 8401157 |
0.485 |
|
| 1991 |
Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. Journal of Clinical Psychopharmacology. 11: 291-5. PMID 1684974 |
0.425 |
|
| Show low-probability matches. |